Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine.

[1]  Laura Sciacca,et al.  Diabetes and cancer. , 2009, Endocrine-related cancer.

[2]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[3]  P. Brennan,et al.  The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study , 2017, Journal of the National Cancer Institute.

[4]  E. Riboli,et al.  Association of CRP genetic variants with blood concentrations of C‐reactive protein and colorectal cancer risk , 2015, International journal of cancer.

[5]  F. Farzadfar,et al.  Obesity-Related Metabolomic Profiles and Discrimination of Metabolically Unhealthy Obesity. , 2018, Journal of proteome research.

[6]  D. Dunger,et al.  Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study , 2002, The Lancet.

[7]  H. Senn,et al.  Insulin-like growth factors and cancer. , 2002, The Lancet. Oncology.

[8]  J. Danesh,et al.  Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data , 2011, BMJ : British Medical Journal.

[9]  J. H. Lee,et al.  Emerging clinical and experimental evidence for the role of lipocalin‐2 in metabolic syndrome , 2012, Clinical and experimental pharmacology & physiology.

[10]  J. Escobar,et al.  Gut microbiota is associated with obesity and cardiometabolic disease in a population in the midst of Westernization , 2018, Scientific Reports.

[11]  F. Clavel-Chapelon,et al.  Serum levels of IGF‐I, IGFBP‐3 and colorectal cancer risk: results from the EPIC cohort, plus a meta‐analysis of prospective studies , 2010, International journal of cancer.

[12]  W. James,et al.  Effect of Plain Versus Sugar‐Sweetened Breakfast on Energy Balance and Metabolic Health: A Randomized Crossover Trial , 2020, Obesity.

[13]  T. Funahashi,et al.  Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy. , 2003, The Journal of clinical endocrinology and metabolism.

[14]  D. Hadrich.  Microbiome Research Is Becoming the Key to Better Understanding Health and Nutrition , 2018, Front. Genet..

[15]  C. Bogardus,et al.  Plasma adiponectin and endogenous glucose production in humans. , 2003, Diabetes care.

[16]  K. Matsuo,et al.  Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: a case–control study in Japan , 2013, BMC Cancer.

[17]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[18]  J. Kuk,et al.  Changes in fat and skeletal muscle with exercise training in obese adolescents: comparison of whole-body MRI and dual energy X-ray absorptiometry , 2013, Obesity.

[19]  Gretchen A. Stevens,et al.  The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis , 2013, PloS one.

[20]  D. Siscovick,et al.  Plasma Fatty Acid–Binding Protein 4, Nonesterified Fatty Acids, and Incident Diabetes in Older Adults , 2012, Diabetes Care.

[21]  Patel J Ashwin,et al.  Leptin and the cardiovascular system: a review. , 2007, Recent patents on cardiovascular drug discovery.

[22]  P. Visscher,et al.  Meta-analysis of genome-wide association studies for height and body mass index in ∼700,000 individuals of European ancestry , 2018, bioRxiv.

[23]  E. Riboli,et al.  Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden) , 2002, Cancer Causes & Control.

[24]  M. Czech.  Insulin action and resistance in obesity and type 2 diabetes , 2017, Nature Medicine.

[25]  M. Copetti,et al.  Association between Resistin Levels and All-Cause and Cardiovascular Mortality: A New Study and a Systematic Review and Meta-Analysis , 2015, PloS one.

[26]  Diana van Heemst,et al.  Insulin, IGF-1 and longevity. , 2010, Aging and disease.

[27]  J. Albu,et al.  Lifestyle, anthropometric, and obesity-related physiologic determinants of insulin-like growth factor-1 in the Third National Health and Nutrition Examination Survey (1988-1994). , 2010, Annals of epidemiology.

[28]  M. Pollak,et al.  Insulin-like Growth Factors and Prostate Cancer , 2001, Cancer and Metastasis Reviews.

[29]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[30]  R. Collins,et al.  Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, Lancet.

[31]  Lei Wu,et al.  Leptin Receptor Gene Polymorphism and the Risk of Cardiovascular Disease: A Systemic Review and Meta-Analysis , 2017, International journal of environmental research and public health.

[32]  D. Mozaffarian,et al.  Fatty acid‐binding protein 4 and incident heart failure: the Cardiovascular Health Study , 2013, European journal of heart failure.

[33]  Y. Song,et al.  Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone , 1997, International Journal of Obesity.

[34]  T. Pischon.  Use of Obesity Biomarkers in Cardiovascular Epidemiology , 2009, Disease markers.

[35]  V. Macaulay,et al.  Insulin-like growth factors and cancer. , 1992, British Journal of Cancer.

[36]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[37]  G. Shulman,et al.  Downregulation of ADIPOQ and PPARγ2 Gene Expression in Subcutaneous Adipose Tissue of Obese Adolescents With Hepatic Steatosis , 2010, Obesity.

[38]  J. Sethi,et al.  Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine , 2016, British journal of pharmacology.

[39]  Shuijun Zhang,et al.  Leptin concentration and risk of coronary heart disease and stroke: A systematic review and meta-analysis , 2017, PloS one.

[40]  N. Kalupahana,et al.  Immunity as a link between obesity and insulin resistance. , 2012, Molecular aspects of medicine.

[41]  A. Engin.  Diet-Induced Obesity and the Mechanism of Leptin Resistance. , 2017, Advances in experimental medicine and biology.

[42]  B. Koletzko,et al.  Metabolomic Biomarkers for Obesity in Humans: A Short Review , 2014, Annals of Nutrition and Metabolism.

[43]  M. Schulze,et al.  General and abdominal adiposity and risk of death in Europe. , 2008, The New England journal of medicine.

[44]  M. Aboul-Ela,et al.  Role of community pharmacists in weight management: results of a national study in Lebanon , 2020, BMC Health Services Research.

[45]  E. Carlsson,et al.  A polymorphism in the adiponectin gene influences adiponectin expression levels in visceral fat in obese subjects , 2006, International Journal of Obesity.

[46]  Jon White,et al.  Role of Adiponectin in Coronary Heart Disease Risk , 2016, Circulation research.

[47]  Herbert Tilg,et al.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.

[48]  R. Gomis,et al.  Proteomics in obesity research , 2009, Proteomics. Clinical applications.

[49]  H. Park,et al.  Relationship between vaspin gene expression and abdominal fat distribution of Korean women. , 2011, Endocrine journal.

[50]  Joel Kullberg,et al.  Measurements of total and regional body composition in preschool children: A comparison of MRI, DXA, and anthropometric data , 2013, Obesity.

[51]  V. Montori,et al.  Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis , 2010, International Journal of Obesity.

[52]  K. Thankappan,et al.  Obesity indicators that best predict type 2 diabetes in an Indian population: insights from the Kerala Diabetes Prevention Program , 2020, Journal of nutritional science.

[53]  T. Liou,et al.  ESR1, FTO, and UCP2 Genes Interact with Bariatric Surgery Affecting Weight Loss and Glycemic Control in Severely Obese Patients , 2011, Obesity surgery.

[54]  P. Sham,et al.  Circulating Adipocyte-Fatty Acid Binding Protein Levels Predict the Development of the Metabolic Syndrome: A 5-Year Prospective Study , 2007, Circulation.

[55]  Tie-Lin Yang,et al.  Gene expression profiles indicate tissue-specific obesity regulation changes and strong obesity relevant tissues , 2018, International Journal of Obesity.

[56]  H. Schiöth,et al.  A Genetic Risk Score Is Associated with Weight Loss Following Roux-en Y Gastric Bypass Surgery , 2016, Obesity Surgery.

[57]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[58]  Tamara S. Roman,et al.  New genetic loci link adipose and insulin biology to body fat distribution , 2014, Nature.

[59]  Aung Ko Win,et al.  Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[60]  C. Dive,et al.  Biological mechanisms linking obesity and cancer risk: new perspectives. , 2010, Annual review of medicine.

[61]  Qianchuan He,et al.  Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies. , 2013, The American journal of clinical nutrition.

[62]  J. M. Goodson,et al.  A Data Mining Approach Identified Salivary Biomarkers That Discriminate between Two Obesity Measures , 2019, Journal of obesity.

[63]  Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data , 2017, Scientific Reports.

[64]  Tracey H. Taveira,et al.  Fasting Serum C‐Peptide Levels Predict Cardiovascular and Overall Death in Nondiabetic Adults , 2012, Journal of the American Heart Association.

[65]  E. Giovannucci,et al.  Plasma Adiponectin and Soluble Leptin Receptor and Risk of Colorectal Cancer: A Prospective Study , 2013, Cancer Prevention Research.

[66]  S. Kahn,et al.  Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.

[67]  P. Pisani.  Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies , 2008, Archives of physiology and biochemistry.

[68]  T. Key,et al.  Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women , 2003, Cancer Causes & Control.

[69]  F. Friedenberg,et al.  Genetic Associations of Obesity: The Fat-Mass and Obesity-Associated (FTO) Gene , 2016, Clinical and Translational Gastroenterology.

[70]  J. Manson,et al.  Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts , 2007, British Journal of Cancer.

[71]  Q. Yao,et al.  Resistin: functional roles and therapeutic considerations for cardiovascular disease , 2012, British journal of pharmacology.

[72]  H. Brenner,et al.  Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe , 2017, British Journal of Cancer.

[73]  T. Pischon,et al.  Body fatness, related biomarkers and cancer risk: an epidemiological perspective , 2015, Hormone molecular biology and clinical investigation.

[74]  G. Franco,et al.  A single FTO gene variant rs9939609 is associated with body weight evolution in a multiethnic extremely obese population that underwent bariatric surgery. , 2015, Nutrition.

[75]  J. Pankow,et al.  Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study , 2013, Cancer Causes and Control.

[76]  Kyoung-Bok Min,et al.  Serum C-peptide levels and risk of death among adults without diabetes mellitus , 2013, Canadian Medical Association Journal.

[77]  M. Zwahlen,et al.  Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. , 2011, The Journal of clinical endocrinology and metabolism.

[78]  F. Clavel-Chapelon,et al.  Adiposity, mediating biomarkers and risk of colon cancer in the European prospective investigation into cancer and nutrition study , 2014, International journal of cancer.

[79]  T. Pischon,et al.  Body mass index, waist circumference, and the risk of type 2 diabetes mellitus: implications for routine clinical practice. , 2010, Deutsches Arzteblatt international.

[80]  A. Rissanen,et al.  Acquired obesity increases CD68 and tumor necrosis factor-alpha and decreases adiponectin gene expression in adipose tissue: a study in monozygotic twins. , 2006, The Journal of clinical endocrinology and metabolism.

[81]  S. Bojesen,et al.  Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  Helen E. Parkinson,et al.  The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog) , 2016, Nucleic Acids Res..

[83]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[84]  Mark Woodward,et al.  Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. , 2011, Lancet.

[85]  M. Fasshauer,et al.  Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. , 2005, Diabetes.

[86]  S. Parlee,et al.  Chemerin: a potential endocrine link between obesity and type 2 diabetes , 2012, Endocrine.

[87]  T. Erlinger,et al.  C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies , 2008, International journal of cancer.

[88]  G. Steinberg,et al.  Adipose tissue as an endocrine organ , 2010, Molecular and Cellular Endocrinology.

[89]  A. Zhang,et al.  Emerging role and recent applications of metabolomics biomarkers in obesity disease research , 2017 .

[90]  M. Schulze,et al.  Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study. , 2016, American journal of epidemiology.

[91]  Ross M. Fraser,et al.  Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.

[92]  Aung Ko Win,et al.  Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer , 2016, British Journal of Cancer.

[93]  T. Romacho,et al.  Visfatin/Nampt: An Adipokine with Cardiovascular Impact , 2013, Mediators of inflammation.

[94]  D. Lawlor,et al.  A systematic review of the association between circulating concentrations of C reactive protein and cancer , 2007, Journal of Epidemiology and Community Health.

[95]  E. Surmacz,et al.  Leptin and cancer , 2006, Journal of cellular physiology.

[96]  Tom R. Gaunt,et al.  Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis , 2017, Circulation.

[97]  Eun-Kyoung Kim,et al.  A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes , 2015, Molecules and cells.

[98]  F. Clavel-Chapelon,et al.  Serum C‐peptide, IGFBP‐1 and IGFBP‐2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition , 2007, International journal of cancer.

[99]  J. Pell,et al.  Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study , 2017, JAMA cardiology.

[100]  V. Choo.  WHO reassesses appropriate body-mass index for Asian populations , 2002, The Lancet.

[101]  Mimi Y. Kim,et al.  Insulin-Like Growth Factor Axis and Risk of Type 2 Diabetes in Women , 2012, Diabetes.

[102]  Tao Xi,et al.  C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis , 2014, Cancer Causes & Control.

[103]  Timothy R Church,et al.  A taxonomic signature of obesity in a large study of American adults , 2018, Scientific Reports.

[104]  J. Reynolds,et al.  Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets. , 2011, Cancer epidemiology.

[105]  Jimmy D Bell,et al.  Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. , 2002, The American journal of clinical nutrition.

[106]  Obesity, genetic risk, and environment , 2014, BMJ : British Medical Journal.

[107]  A. Valsesia,et al.  Transcriptome profiling from adipose tissue during a low-calorie diet reveals predictors of weight and glycemic outcomes in obese, nondiabetic subjects. , 2017, The American journal of clinical nutrition.

[108]  M. Suárez-Fariñas,et al.  Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis. , 2011, The American journal of clinical nutrition.

[109]  G. Casey,et al.  FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African-Americans. , 2011, Carcinogenesis.

[110]  R. Wolff,et al.  Leptin and colorectal cancer: an undefined link , 2007, Nature Clinical Practice Gastroenterology &Hepatology.

[111]  L. Kappelle,et al.  Adiponectin and incident coronary heart disease and stroke. A systematic review and meta‐analysis of prospective studies , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[112]  E. Rimm,et al.  Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer: a Mendelian Randomization analysis using data from three large cohort studies , 2017, European Journal of Epidemiology.

[113]  Joanna D. Holbrook,et al.  Resistin is expressed in human macrophages and directly regulated by PPARγ activators , 2003 .

[114]  D. Albanes,et al.  Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. , 2005, JAMA.

[115]  Sung-Ae Jung,et al.  Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. , 2010, Molecular endocrinology.

[116]  M. Zhu,et al.  Meta‐analysis: Circulating adiponectin levels and risk of colorectal cancer and adenoma , 2011, Journal of digestive diseases.

[117]  François G. Meyer,et al.  Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies , 2008, Annals of Internal Medicine.

[118]  N. Habermann,et al.  Gene Expression Changes in Adipose Tissue with Diet- and/or Exercise-Induced Weight Loss , 2013, Cancer Prevention Research.

[119]  C. Friedenreich,et al.  Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). , 2006, Journal of the National Cancer Institute.

[120]  Yuansi Chen,et al.  Anthropometric indices as surrogates for estimating abdominal visceral and subcutaneous adipose tissue: A meta-analysis with 16,129 participants. , 2018, Diabetes research and clinical practice.

[121]  R. Henry,et al.  Adiponectin: more than just another fat cell hormone? , 2003, Diabetes care.

[122]  A. Peters,et al.  Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.

[123]  S. Delorme,et al.  Validation of Anthropometric Indices of Adiposity against Whole-Body Magnetic Resonance Imaging – A Study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) Cohorts , 2014, PloS one.

[124]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[125]  H. Rosenberg,et al.  Cytokine Diversity in Human Peripheral Blood Eosinophils: Profound Variability of IL-16 , 2019, The Journal of Immunology.

[126]  H. Kwon,et al.  Adipokines Mediate Inflammation and Insulin Resistance , 2013, Front. Endocrinol..

[127]  Diana Wald,et al.  Automatic quantification of subcutaneous and visceral adipose tissue from whole‐body magnetic resonance images suitable for large cohort studies , 2012, Journal of magnetic resonance imaging : JMRI.

[128]  Inês Barroso,et al.  The genetics of obesity: FTO leads the way , 2010, Trends in genetics : TIG.

[129]  F. Clavel-Chapelon,et al.  Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study. , 2012, Carcinogenesis.

[130]  Tran Quoc Bao,et al.  Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants , 2016, The Lancet.

[131]  G. Norata,et al.  Plasma resistin levels correlate with determinants of the metabolic syndrome. , 2007, European journal of endocrinology.

[132]  Andrew W Roddam,et al.  Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies , 2010, The Lancet. Oncology.

[133]  B. Henderson,et al.  Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[134]  Stacey A. Kenfield,et al.  Plasma insulin‐like growth factor 1 is positively associated with low‐grade prostate cancer in the Health Professionals Follow‐up Study 1993–2004 , 2011, International journal of cancer.

[135]  E. Giovannucci.  Insulin, insulin-like growth factors and colon cancer: a review of the evidence. , 2001, The Journal of nutrition.

[136]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[137]  R. Ross.  Advances in the application of imaging methods in applied and clinical physiology , 2003, Acta Diabetologica.

[138]  G. Reaven.  Insulin resistance: the link between obesity and cardiovascular disease. , 2011, The Medical clinics of North America.

[139]  W. Kim,et al.  Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis. , 2014, World journal of gastroenterology.

[140]  W. Rathmann,et al.  Association of longitudinal risk profile trajectory clusters with adipose tissue depots measured by magnetic resonance imaging , 2019, Scientific Reports.

[141]  C. Gardner,et al.  A systematic review of studies of DNA methylation in the context of a weight loss intervention. , 2017, Epigenomics.

[142]  Shigeru Okada,et al.  A proteomic approach to obesity and type 2 diabetes , 2015, Journal of cellular and molecular medicine.

[143]  C. Newgard,et al.  Metabolomics and Metabolic Diseases: Where Do We Stand? , 2017, Cell metabolism.

[144]  R. Kaaks,et al.  Energy balance and cancer: the role of insulin and insulin-like growth factor-I , 2001, The Proceedings of the Nutrition Society.

[145]  M. Beckmann,et al.  Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[146]  W. Pan,et al.  How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. , 2008, Asia Pacific journal of clinical nutrition.

[147]  Tom R. Gaunt,et al.  The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium , 2015, Cancer Causes & Control.

[148]  P. Delafontaine,et al.  Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging. , 2014, Frontiers of hormone research.

[149]  A. Rogol,et al.  Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose. , 2005, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[150]  C. Kusminski,et al.  Role of resistin in obesity, insulin resistance and Type II diabetes. , 2005, Clinical science.